Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | MAOA | P21397 | 7/20 | 0.59 |
| ▸ | MAOB | P27338 | 6/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | BRD4 | O60885 | 1/20 | 0.51 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30648399 | 0.98 | ALDH1A1 (0.58) | ALDH1A1MAOAMAOBEPHX2HTT | |
| SCHEMBL3831209 | 0.83 | MAOA (0.44) | ALDH1A1MAOAMAOBEPHX2HTT | |
| SCHEMBL6345921 | 0.80 | ALDH1A1 (0.56) | ALDH1A1MAOAMAOBEPHX2HTT | |
| SCHEMBL1756087 | 0.80 | HDAC1 (0.51) | ALDH1A1MAOAEPHX2BRD4CREBBP | |
| SCHEMBL9628996 | 0.77 | MAPT (0.53) | ALDH1A1MAOAMAOBEPHX2BRD4 | |
| SCHEMBL7998823 | 0.77 | MAOB (0.53) | ALDH1A1MAOAMAOBEPHX2HTT | |
| SCHEMBL4653865 | 0.77 | HTT (0.62) | ALDH1A1MAOAMAOBEPHX2HTT | |
| SCHEMBL4258367 | 0.77 | HTT (0.59) | ALDH1A1MAOAMAOBEPHX2HTT | |
| Phenothiazine SCHEMBL29051430 | 0.77 | GSK3A (0.58) | ALDH1A1MAOAMAOBEPHX2HTT | |
| SCHEMBL3428710 | 0.76 | L3MBTL1 (0.50) | ALDH1A1MAOAMAOBEPHX2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720318-A1 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GLYOXAL | Solugen, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-3768675-B1 | NOVEL TRIAZOLONE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | YUHAN CORP (KR) | 2026-04-01 | — | — | EP | claimed |
| US-12390473-B2 | Methods of treating tyrosine kinase inhibitor-induced diarrhea | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-08-19 | — | — | US | claimed |
| EP-4583977-A1 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2025-07-16 | — | — | EP | claimed |
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | SOLUGEN, INC. (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025076549-A1 | SMALL MOLECULE ACTIVATORS | SOLUGEN, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| WO-2024249896-A1 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GLYOXAL | SOLUGEN, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| WO-2024170772-A1 | EPIGALLOCATECHIN-3-GALLATE (EGCG) ANALOGS FOR USE IN THE TREATMENT OF DISEASES IN WHICH AN INCREASE OF NAD+ IS BENEFICIAL SUCH AS GLAUCOMA | MIM NEUROSCIENCES AB (SE) | 2024-08-22 | — | — | WO | claimed |
| WO-2024052512-A1 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2024-03-14 | — | — | WO | claimed |
| CN-111886233-B | Triazolone derivatives or salts thereof and pharmaceutical compositions containing the same | 柳韩洋行 | 2024-01-02 | — | — | CN | claimed |
| EP-1362577-B1 | Hair dye composition | KAO CORP (JP) | 2006-07-12 | — | — | EP | claimed |
| EP-1362577-A1 | Hair dye composition | Kao Corporation (JP) | 2003-11-19 | — | — | EP | claimed |
| US-20030187256-A1 | Benoxazinones/benzothiazinones as serine protease inhibitors | BERRYMAN KENT ALAN (US) | 2003-10-02 | — | — | US | claimed |
| EP-1068191-A1 | BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2001-01-17 | — | — | EP | claimed |
| EP-0627425-B1 | 3-OXO-1,4-BENZOTHIAZINE DERIVATIVE | SANTEN PHARMACEUTICAL CO LTD (JP) | 2000-11-02 | — | — | EP | claimed |
| WO-1999050257-A1 | BENZOXAZINONES/BENZOTHIAZINONES AS SERINE PROTEASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1999-10-07 | — | — | WO | claimed |
| EP-0463945-B1 | Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1995-12-27 | — | — | EP | claimed |
| EP-0463945-A1 | Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1992-01-02 | — | — | EP | claimed |
| US-4535079-A | HYPOTENSIVE, ANTIARRHYTHMIA, ADRENERGIC BLOCKING AGENTS; VASODILATORS | MEDIOLANUM FARMACEUTICI S.R.L. (IT) | 1985-08-13 | — | — | US | claimed |
| EP-0106816-A2 | Alkanolaminoxy derivatives of 3,4-dihydro-2H-1,4-benzothiazin-3-one, their production process, and their pharmaceutical use | MEDIOLANUM FARMACEUTICI s.r.l. (IT) | 1984-04-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | G6PD, SOD1, UGDH | ALDH1A1 229/4885MAOA 554/4885MAOB 1098/4885 |
| US-12390473-B2 | Methods of treating tyrosine kinase inhibitor-induced diarrhea | CFTR, LCK, ABL1 | ALDH1A1 3634/4885MAOA 4517/4885MAOB 3709/4885 |
| US-20030187256-A1 | Benoxazinones/benzothiazinones as serine protease inhibitors | HABP2, SPINT2, SERPINB1 | ALDH1A1 2444/4885MAOA 340/4885MAOB 593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.